TransCode Therapeutics, Inc. earnings per share and revenue

RNAZ earnings per share for the last quarter are -0.16 USD whereas the estimation was -16.17 USD which accounts for 99.01% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 300.00 k USD. Estimated earnings per share for the next quarter are -3.21 USD, and revenue is expected to reach 300.00 k USD. Also watch annual changes over time to get a bigger picture of RNAZ earnings per share and revenue dynamics.